Skip to main content
    D

    Disc Medicine Inc. (IRON)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • NASDAQ

    $56.65
    +0.91 (+1.63%)

    Market Cap: $2.14B

    Last updated: Oct 16, 2026 at 1:55 PM ET

    Earnings

    Performance (10Y)

    Beat Rate
    65%(15/23)
    Avg Surprise
    -2.76%
    Streak
    3 Q

    Upcoming Estimates

    Period ending Sep 30, 2026
    EPS Consensus$-1.71
    Range$-1.93 - $-1.47
    9 analysts
    EPS Revisions
    1
    0
    7d
    1
    1
    30d
    EPS Estimate DriftChange to current
    90d ago$-1.86+7.8%
    60d ago$-1.86+7.8%
    30d ago$-1.74+1.6%
    7d ago$-1.74+1.6%
    Current$-1.71
    Revenue Consensus
    $0
    Range$0 - $0
    10 analysts
    Period ending Dec 31, 2026
    EPS Consensus$-1.35
    Range$-2.03 - $-0.19
    9 analysts
    Revenue Consensus
    $-50000
    Range$-50000 - $-50000
    11 analysts
    PeriodReportedEst.SurpriseB/MYoY
    Dec 26EST
    		-$-1.35---
    Sep 26EST
    		-$-1.71---
    Jun 26
    Reported Jul 30
    		$-1.54$-1.58+2.53%Beat+2.5%
    Mar 26
    Reported May 5
    		$-1.65$-1.73+4.62%Beat-61.8%
    Dec 25
    Reported Feb 26
    		$-1.62$-1.69+4.14%Beat-65.3%
    Sep 25
    Reported Nov 6
    		$-1.77$-1.46-21.23%Miss-98.9%
    Jun 25
    Reported Aug 7
    		$-1.58$-1.17-35.04%Miss-53.4%
    Mar 25
    Reported May 7
    		$-1.02$-1.07+4.67%Beat+6.4%
    Dec 24
    Reported Feb 27
    		$-0.98$-1.10+11.20%Beat-8.9%
    Sep 24
    Reported Nov 12
    		$-0.89$-1.05+15.24%Beat-53.4%
    Jun 24
    Reported Aug 8
    		$-1.03$-1.10+6.36%Beat-39.2%
    Mar 24
    Reported May 9
    		$-1.09$-0.99-10.10%Miss+9.2%
    Dec 23
    Reported Mar 21
    		$-0.90$-0.78-15.38%Miss+26.2%
    Sep 23
    Reported Nov 9
    		$-0.58$-0.80+27.50%Beat-625.0%
    Jun 23
    Reported Aug 11
    		$-0.74$-0.89+16.85%Beat+53.8%
    Mar 23
    Reported May 15
    		$-1.20$-0.66-81.82%Miss+65.7%
    Dec 22
    Reported Mar 31
    		$-1.22$-0.76-60.53%Miss+70.2%
    Sep 22
    Reported Nov 10
    		$-0.08$-0.09+11.11%Beat+98.1%
    Jun 22
    Reported Aug 11
    		$-1.60$-2.00+20.00%Beat+57.9%
    Mar 22
    Reported May 6
    		$-3.50$-3.01-16.28%Miss+40.7%
    Dec 21
    Reported Mar 10
    		$-4.10$-4.97+17.50%Beat-102.0%
    Sep 21
    Reported Nov 15
    		$-4.30$-4.73+9.09%Beat-10650.0%
    Jun 21
    Reported Aug 12
    		$-3.80$-4.00+5.00%Beat-
    Mar 21
    Reported May 13
    		$-5.90$-3.65-61.64%Miss-
    Dec 20
    Reported Jan 19
    		$-2.03N/A+82.80%Beat-
    Sep 20
    Reported Nov 12
    		$-0.04$0.00N/AMiss-
    Jun 20
    Reported Aug 13
    		$0.00$0.00N/ABeat-

    Key Metrics

    Valuation
    P/E Ratio-8.61EV/EBITDAN/A
    Price/FCFN/AFCF YieldN/A
    Profitability
    Profit Margin0.00%Operating Margin0.00%
    ROE-39.10%ROIC-38.28%
    Financial Health
    Debt/Equity0.09xInterest Coverage-75.81x
    Current Ratio24.14xQuick Ratio24.14x
    Trading Statistics
    Beta2.11Avg Volume644.07K
    52-Week High$99.5052-Week Low$40.00

    Technical Indicators Dashboard

    Moving Averages

    SMA 10$60.30
    SMA 20$63.35
    SMA 50$71.92
    SMA 200$70.76
    EMA 10$59.87
    EMA 20$63.09
    EMA 50$68.41
    EMA 200$70.34

    MACD

    Line: -4.08Signal: -3.66Hist: -0.42

    ADX

    ADX: 46.1+DI: 8.1-DI: 31.3

    Aroon & PSAR

    Aroon UpN/A
    Aroon Down96.0
    PSAR$62.47

    Bollinger Bands

    Upper Band$71.29
    Lower Band$55.42
    %B Position2504%(Upper)
    Band Width0.08

    RSI (14-Day)

    Oversold
    24.4

    Momentum Oscillators

    Stoch %K4.7
    Stoch %D10.5
    Williams %R-89.4
    ROC (10d)-10.9%
    Momentum-6.96
    CCI (20d)-148.2
    MFI (14d)29.4

    Volatility Measures

    ATR (14d)$2.92(5.1%)
    StdDev (20d)3.97
    Hist Vol32.7%(Moderate)

    Volume Flow

    VWAP$56.90
    OBV2.4M
    AD Line-1.1M
    CMF (20d)-0.184

    Volume Metrics

    Avg Vol (20d)655.7K
    Vol Ratio1.1x
    VWMA (20d)$63.30

    Pivot Points

    R3$61.24
    R2$60.04
    R1$57.89
    Pivot Point$56.69
    S1$54.53
    S2$53.33
    S3$51.18

    Advanced Oscillators

    TSI-50.13
    Ultimate Osc33.1
    KST-176.26

    Financial Data

    QuarterJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023Sep 2023
    Total Revenue$0$0$-19,884,127$0$0$0$0$0$0$0$0$0
    Cost of Revenue$0$0$89,000$0$0$0$9,000$0$0$0$25,000$0
    Gross Profit$0$0$-89,000$0$0$0$-9,000$0$0$0$-25,000$0
    Operating Expenses$65.08M$69.52M$66.97M$67.70M$61.41M$39.95M$34.55M$32.86M$30.85M$31.46M$29.71M$18.96M
    R&D$46.93M$45.90M$46.22M$50.33M$46.32M$27.76M$24.80M$24.68M$23.48M$23.70M$22.57M$14.42M
    SG&A$18.14M$23.62M$20.75M$17.36M$15.09M$12.18M$9.75M$8.17M$7.37M$7.76M$7.15M$4.54M
    Operating Income$-65,075,000$-69,524,000$-66,970,000$-67,696,000$-61,410,000$-39,946,000$-34,550,000$-32,856,000$-30,852,000$-31,462,000$-29,714,000$-18,958,000
    Interest Income$6.53M$6.89M$7.41M$6.41M$7.06M$6.88M$5.84M$6.36M$4.57M$4.52M$4.68M$4.84M
    Interest Expense$908,000$844,000$883,000$917,000$910,000$897,000$0$0$0$0$0$0
    Income Before Tax$-59,463,000$-63,453,000$-60,443,000$-62,219,000$-55,195,000$-33,966,000$-29,281,000$-26,485,000$-26,292,000$-26,944,000$-23,547,000$-14,102,000
    Income Tax Expense$69,000$51,000$88,000$102,000$52,000$119,000$176,000$114,000$60,000$5,000$32,000$20,000
    Net Income$-59,532,000$-63,504,000$-60,531,000$-62,321,000$-55,247,000$-34,085,000$-29,457,000$-26,599,000$-26,352,000$-26,949,000$-23,579,000$-14,122,000
    EBITDA$-65,486,000$-70,482,000$-68,515,000$-69,366,000$-63,878,000$-42,456,000$-36,750,000$-35,332,000$-31,351,000$-31,437,000$-28,199,000$-18,920,000
    EBIT$-65,087,000$-69,502,000$-66,972,000$-67,714,000$-61,342,000$-39,949,000$-34,547,000$-32,847,000$-30,865,000$-31,463,000$-28,224,000$-18,945,000
    * Some calculated fields are derived from available data when not provided by source

    Related GNG Research

    No research available

    Be the first to write about IRON

    News

    Disc Medicine, Inc. (NASDAQ:IRON) Stock Has Average Target Price of $110.18

    Thirteen brokerages have given Disc Medicine, Inc. (NASDAQ:IRON) a consensus "Moderate Buy" rating, with an average 12-month price target of $110.18...

    MarketBeat•10/16/26•Bullish

    10 Health Care Stocks With Whale Alerts In Today’s Session

    This article identifies ten healthcare stocks with significant options activity, known as "whale alerts," that could indicate potential trading opportunities. It details specific call and put options trades for companies...

    Benzinga•10/12/26•Bearish

    Understanding Momentum Shifts in (IRON)

    This article analyzes Disc Medicine Inc. (NASDAQ: IRON), highlighting weak sentiment across all time horizons. It presents an exceptional 71.1:1 risk-reward setup targeting a 20.3% gain against a 0.3% risk...

    Stock Traders Daily•10/12/26•Bearish

    Disc Medicine Q3 2026 Earnings Date and Estimates

    Disc Medicine (NASDAQ: IRON) is projected to announce its Q3 2026 earnings on Thursday, November 5, 2026, before the market opens, with a conference call scheduled for October 30...

    MarketBeat•10/10/26•Neutral

    Disc Medicine Investor News: If You Have Suffered Losses in

    The Rosen Law Firm is investigating potential securities claims against Disc Medicine, Inc. (NASDAQ: IRON) after the FDA issued a Complete Response Letter regarding its bitopertin program...

    GlobeNewswire•10/6/26•Bearish

    IRON Valuation and Fair Value

    P/E
    -8.6x
    P/B
    3.4x
    See GNG's fair value

    IRON Profitability: Margins, ROIC and FCF

    Operating margin
    0.0%
    Net margin
    0.0%
    ROIC
    -38.3%
    ROE
    -39.1%

    IRON Competitors

    CompanyTicker
    Aurinia Pharmaceuticals IncAUPH
    Progyny IncPGNY
    Harmony Biosciences HoldingsHRMY
    Dynavax Technologies CorporationDVAX
    Celldex Therapeutics IncCLDX
    Pharvaris BVPHVS
    NeoGenomics IncNEO
    Avadel Pharmaceuticals PLCAVDL

    Sector: Healthcare

    IRON Analyst Ratings

    Consensus
    Buy
    Analysts
    13
    Strong Buy
    1
    Buy
    12
    Hold
    0
    Sell
    0
    Strong Sell
    0

    IRON Bull Case vs Bear Case

    Bull case

    • IRON beat EPS estimates in 75.0% of its last 8 reported quarters.
    • 100.0% of IRON's analyst ratings are Buy or Strong Buy.

    IRON Earnings: Beat Rate and Next Report

    Beat rate
    6 of 8 quarters (75.0%)
    Average surprise
    -1.7%
    EPS estimate (fiscal period ending Sep 30, 2026)
    $-1.71
    Estimate revisions (30 days, fiscal period ending Sep 30, 2026)
    1 up, 1 down

    Frequently Asked Questions About IRON

    Does IRON pay dividends?

    Disc Medicine Inc. (IRON) does not currently pay a regular dividend.

    What is IRON's market cap?

    Disc Medicine Inc. (IRON) has a market capitalization of $2.14B with a current stock price of $56.65.

    Related stocks

    Sector: Healthcare

    All stocks starting with I

    Get full access to GNG Research

    Create a free account to access portfolio tracking, advanced tools, and more.

    Create Free AccountLog In